• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 57 of 100
Jury Deliberations Continue In Martin Shkreli Securities Fraud Trial
Tech‘Pharma Bro’ Martin Shkreli Heads to Jail For Placing Bounty on Hillary Clinton’s Hair
By ReutersSeptember 13, 2017
Key Speakers At 16th Nikkei Global Management Forum 2014
HealthStruggling Israeli Generics Maker Teva Finally Names New CEO
By Natasha BachSeptember 11, 2017
CNBC Events
HealthBotox Maker Allergan’s CEO Defends Selling Drug Patents to Native American Tribe to Thwart Rivals
By Sy MukherjeeSeptember 9, 2017
Former Turing Pharmaceuticals CEO Martin Shkreli On Trial For Securities Fraud
LeadershipProsecutors Want Martin Shkreli Jailed After Hillary Clinton Hair ‘Threat’
By Lucinda ShenSeptember 8, 2017
Businessman with Duchenne muscular dystrophy in a motorized wheelchair working in an office
HealthThis Controversial Biotech May Yet Defy Its Skeptics
By Sy MukherjeeSeptember 6, 2017
Novartis CEO Joe Jimenez Interview and Tour of $1 Billion Research Center
HealthNovartis CEO Joseph Jimenez Is Stepping Down
By David MeyerSeptember 4, 2017
Is $475,000 Too High a Price for Novartis’s ‘Historic’ Cancer Gene Therapy?
HealthIs $475,000 Too High a Price for Novartis’s ‘Historic’ Cancer Gene Therapy?
By Sy MukherjeeAugust 31, 2017
Novartis CEO Joe Jimenez Interview and Tour of $1 Billion Research Center
HealthThe Way We Treat Cancer Will Be Revolutionized As Gene Therapy Comes to the U.S.
By Sy MukherjeeAugust 30, 2017
Elijah Cummings, Peter Welch
HealthHouse Democrats Start Multiple Sclerosis Drug Price Probe
By BloombergAugust 17, 2017
Fosun International Ltd. Chairman And Billionaire Guo Guangchang Attends Interim Results News Conference
FinanceChina’s Fosun Is Defying Beijing’s Crackdown on Debt and Foreign M&A
By Fortune Editors and ReutersAugust 14, 2017
Forbes Under 30 Summit
HealthWhy SoftBank Made a Record-Breaking $1.1 Billion Bet on This Biotech Firm
By Sy MukherjeeAugust 9, 2017
Why Martin Shkreli Won’t Be the Last Pharma Bro
CommentaryWhy Martin Shkreli Won’t Be the Last Pharma Bro
By Josh HoxieAugust 8, 2017
Hepatitis C drug can cure, if patients can get it
HealthThe FDA Just Approved the First Drug That Can Treat All Hepatitis C Strains in Just 8 Weeks
By Sy MukherjeeAugust 3, 2017
Inside Teva Pharmaceuticals Headquarters
FinancePharma Giant Teva’s Stock Is Imploding As Generic Drugs Get Cheaper
By BloombergAugust 3, 2017
Jury Deliberations Continue In Martin Shkreli Securities Fraud Trial
FinanceJury in Martin Shkreli Trial Asks the Judge to Define ‘Fraudulent Intent’
By ReutersAugust 1, 2017
1...
  • 55
  • 56
  • 57
  • 58
  • 59
...100
Most Popular
Success
CEO of $20 billion AI firm Perplexity says the secret to success is ‘sleeping with that fear’ that your competitor will steal your ideaplaceholder alt text
By Preston ForeJune 13, 2026
Personal Finance
Social Security's 2032 deadline puts a 22% cut on the table — but Washington has way less room to negotiate than 1983placeholder alt text
By John W. Diamond and The ConversationJune 12, 2026
Personal Finance
Current price of oil as of June 15, 2026placeholder alt text
By Joseph HostetlerJune 15, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.